Media Releases

2022

29/08/2022

Proteomics, UWA join forces on new diagnostic test – The West Australian

29/08/2022

OxiDx launched to maximise oxidative stress technology

15/08/2022

Proteomics International raises $8m in highly successful Placement

09/08/2022

Proteomics International signs binding letter of intent with Sonic Healthcare USA to take PromarkerD into the US market

02/08/2022

American doctors give tick to Proteomics kidney test – The West Australian

02/08/2022

Clinical Utility Study demonstrates PromarkerD test benefits

01/08/2022

Potential breakthrough blood test able to detect people with endometriosis

01/08/2022

Boost for Proteomics in fight against painful disorder – The West Australian

25/07/2022

European PromarkerD patents expanded beyond diabetes

30/06/2022

Promarker™ pipeline – Endometriosis update Diagnostic readout positive: Study expanded

28/06/2022

QIMR Berghofer Licenses Esophageal Cancer Blood Biomarkers to Proteomics International – Precision Oncology News

21/06/2022

Proteomics International (ASX:PIQ) secures licence for oesophageal cancer biomarkers – The Market Herald

21/06/2022

Proteomics International secures exclusive licence to oesophageal cancer biomarkers

16/06/2022

Pilot test kit takes Proteomics step closer to sales – The West Australian

16/06/2022

Proteomics International Laboratories (ASX:PIQ) completes PromarkerD manufacturing tech transfer – The Market Herald

1
…
6
7
8
9
10
11
12
…
27